Genetic Basis for Sex Differences in Obesity and Lipid Metabolism

Annual Review of Nutrition

Volumn 37, Issue , 2017, Pages 225-245

  Link, Jenny C ^a   Reue, Karen ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adipose tissue; Glucose metabolism; Gonadal hormones; Metabolic syndrome; Microbiome; Sex chromosome complement

Indexed keywords

SEX HORMONE;

ANIMAL; FEMALE; GENETICS; HUMAN; LIPID METABOLISM; MALE; MOUSE; OBESITY; SEX CHROMOSOME; SEX DIFFERENCE; SEXUAL DEVELOPMENT;

ANIMALS; FEMALE; GONADAL HORMONES; HUMANS; LIPID METABOLISM; MALE; MICE; OBESITY; SEX CHARACTERISTICS; SEX CHROMOSOMES; SEX FACTORS;

EID: 85018860070     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071816-064827     Document Type: Review

References (125)

1. Ahmed-Sorour H, Bailey CJ. 1981. Role of ovarian hormones in the long-term control of glucose homeostasis, glycogen formation and gluconeogenesis. Ann. Nutr. Metab. 25:208-12
2. Angulo P. 2002. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346:1221-31
3. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. 2011. Clinical review: Endogenous testosterone and mortality in men: A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96:3007-19
4. Arnold AP. 2009. Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J. Neuroendocrinol. 21:377-86
5. Arnold AP, Burgoyne PS. 2004. Are XX and XY brain cells intrinsically different? Trends Endocrinol. Metab. 15:6-11
6. Arnold AP, Chen X. 2009. What does the "four core genotypes" mousemodel tell us about sex differences in the brain and other tissues? Front. Neuroendocrinol. 30:1-9
7. Arnold AP, Chen X, Link JC, Itoh Y, Reue K. 2013. Cell-autonomous sex determination outside of the gonad. Dev. Dyn. 242:371-79
8. Arnold AP, Reue K, Eghbali M, Vilain E, Chen X, et al. 2016. The importance of having two X chromosomes. Philos. Trans. R. Soc. B 371:20150113
9. Bartlett J, Predazzi IM, Williams SM, Bush WS, Kim Y, et al. 2016. Is isolated low high-density lipoprotein cholesterol a cardiovascular disease risk factor? New insights from the Framingham offspring study. Circ. Cardiovasc. Qual. Outcomes 9:206-12
10. Becker JB, Prendergast BJ, Liang JW. 2016. Female rats are not more variable than male rats: A metaanalysis of neuroscience studies. Biol. Sex Differ. 7:34
11. Bittner V. 2005. Perspectives on dyslipidemia and coronary heart disease in women. J. Am. Coll. Cardiol. 46:1628-35
12. Blouin K, Boivin A, Tchernof A. 2008. Androgens and body fat distribution. J. Steroid Biochem.Mol. Biol. 108:272-80
13. Bojesen A, Høst C, Gravholt CH. 2010. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: The impact of body composition. Mol. Hum. Reprod. 16:396-401
14. Bojesen A, Kristensen K, Birkebaek NH, Fedder J, Mosekilde L, et al. 2006. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 29:1591-98
15. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, et al. 2004. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 40:1387-95
16. Bukowski R, Smith GCS, Malone FD, Ball RH, Nyberg DA, et al. 2007. Human sexual size dimorphism in early pregnancy. Am. J. Epidemiol. 165:1216-18
17. Burgoyne PS. 1993. A Y-chromosomal effect on blastocyst cell number in mice. Development 117:341-45
18. Burgoyne PS, Thornhill AR, Boudrean SK, Darling SM, Bishop CE, Evans EP. 1995. The genetic basis of XX-XY differences present before gonadal sex differentiation in the mouse. Philos. Trans. R. Soc. B. 350:253-61
19. Calcaterra V, Brambilla P, Maffè GC, Klersy C, Albertini R, et al. 2014. Metabolic syndrome in Turner syndrome and relation between body composition and clinical, genetic, and ultrasonographic characteristics. Metab. Syndr. Relat. Disord. 12:159-64
20. Castelli WP, Anderson K, Wilson PW, Levy D. 1992. Lipids and risk of coronary heart disease. The Framingham Study. Ann. Epidemiol. 2:23-28
21. Chen X, Mc Clusky R, Chen J, Beaven SW, Tontonoz P, et al. 2012. The number of X chromosomes causes sex differences in adiposity in mice. PLOS Genet. 8:e1002709
22. Chen X, Wang L, Loh DH, Colwell CS, Tache Y, et al. 2015. Sex differences in diurnal rhythms of food intake in mice caused by gonadal hormones and complement of sex chromosomes. Horm. Behav. 75:55-63
23. Chen X, Williams-Burris SM, Mc Clusky R, Ngun TC, Ghahramani N, et al. 2013. The sex chromosome trisomy mouse model of XXY and XYY: Metabolism and motor performance. Biol. Sex Differ. 4:15
24. Cfkova R, Kraj?coviechova A. 2015. Dyslipidemia and cardiovascular disease in women. Curr. Cardiol. Rep. 17:609
25. Clark JM, Brancati FL, Diehl AM. 2003. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 98:960-67
26. Clayton JA, Collins FS. 2014. Policy: NIH to balance sex in cell and animal studies. Nature 509:282-83
27. Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: An integrative view. Cell 148:1258-70
28. Cohen JC, Horton JD, Hobbs HH. 2011. Human fatty liver disease: Old questions and new insights. Science 332:1519-23
29. Collins P. 2008. HDL-C in post-menopausal women: An important therapeutic target. Int. J. Cardiol. 124:275-82
30. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, et al. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J.Med. 334:292-95
31. Czy?zyk A, M-eczekalski B. 2012. Cardiovascular and metabolic problems in Turner's syndrome patients. Arch. Perinat. Med. 18:47-52
32. Danska JS. 2014. Sex matters for mechanism. Sci. Transl. Med. 6:258fs40
33. Du S, Itoh N, Askarinam S, Hill H, Arnold AP, Voskuhl RR. 2014. XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. PNAS 111:2806-11
34. Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, et al. 2008. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am. J. Gastroenterol. 103:2263-71
35. Eyre H, Kahn R, Robertson RM, Am. Cancer Soc., Am. Diabetes Assoc., Am. Heart Assoc. Collab. Writ. Comm. 2004. Preventing cancer, cardiovascular disease, and diabetes: A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Diabetes Care 27:1812-24
36. Fan WQ, Yanase T, Nomura M, Okabe T, Goto K, et al. 2005. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54:1000-8
37. Fox CS, Liu Y, White CC, Feitosa M, Smith A V, et al. 2012. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat inwomen. PLOS Genet. 8:e1002695
38. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, et al. 2007. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39-48
39. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, et al. 2004. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: The Framingham Study. Clin. Chem. 50:1189-200
40. Fried SK, Lee MJ, Karastergiou K. 2015. Shaping fat distribution: New insights into the molecular determinants of depot-and sex-dependent adipose biology. Obesity 23:1345-52
41. Garaulet M, Perez-Llamas F, Baraza JC, Garcia-Prieto MD, Fardy PS, et al. 2002. Body fat distribution in pre-and post-menopausal women: Metabolic and anthropometric variables. J. Nutr. Health Aging 6:123-26
42. Geer EB, Shen W. 2009. Gender differences in insulin resistance, body composition, and energy balance. Gend. Med. 6(Suppl. 1):60-75
43. Goff DC, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, et al. 2006. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): Gender, ethnicity, and coronary artery calcium. Circulation 113:647-56
44. Gravholt CH. 2004. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur. J. Endocrinol. 151:657-87
45. Grove KL, Fried SK, Greenberg AS, Xiao XQ, Clegg DJ. 2010. A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice. Int. J. Obes. 34:989-1000
46. Consort GTEx. 2015. Human genomics. The genotype-tissue expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science 348:648-60
47. Gurka MJ, Lilly CL, Oliver MN, De Boer MD. 2014. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: A confirmatory factor analysis and a resulting continuous severity score. Metabolism 63:218-25
48. Hagen CP, Main KM, Kjaergaard S, Juul A. 2010. FSH, LH, inhibin B and estradiol levels in Turner syndrome depend on age and karyotype: Longitudinal study of 70 Turner girls with or without spontaneous puberty. Hum. Reprod. 25:3134-41
49. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. 1997. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 20:1859-62
50. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, et al. 2010. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42:949-60
51. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. 2000. Increased adipose tissue in male and female estrogen receptor-?knockout mice. PNAS 97:12729-34
52. Herrera BM, Lindgren CM. 2010. The genetics of obesity. Curr. Diabetes Rep. 10:498-505
53. Høst C, Skakkebæk A, Groth KA, Bojesen A. 2014. The role of hypogonadism in Klinefelter syndrome. Asian J. Androl. 16:185-91
54. Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, et al. 2005. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: A meta-analysis. Clin. Endocrinol. 63:280-93
55. Itoh Y, Arnold AP. 2015. Are females more variable than males in gene expression? Meta-analysis of microarray datasets. Biol. Sex Differ. 6:18
56. Itoh Y, Mackie R, Kampf K, Domadia S, Brown JD, et al. 2015. Four core genotypes mouse model: Localization of the Sry transgene and bioassay for testicular hormone levels. BMC Res. Notes 8:69
57. Jeffery E, Wing A, Holtrup B, Sebo Z, Kaplan JL, et al. 2016. The adipose tissue microenvironment regulates depot-specific adipogenesis in obesity. Cell Metab. 24:142-50
58. Johnson JL, Slentz CA, Duscha BD, Samsa GP, Mc Cartney JS, et al. 2004. Gender and racial differences in lipoprotein subclass distributions: The STRRIDE study. Atherosclerosis 176:371-77
59. Karakelides H, Irving BA, Short KR, O'Brien P, Nair KS. 2010. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes 59:89-97
60. Karastergiou K, Fried SK. 2012. Sex differences in human adipose tissues: The biology of pear shape. Biol. Sex Differ. 3:13
61. Krebs CJ, Zhang D, Yin L, Robins DM. 2014. The KRAB zinc finger protein RSL1modulates sex-biased gene expression in liver and adipose tissue to maintain metabolic homeostasis. Mol. Cell. Biol. 34:221-32
62. Kuk JL, Ardern CI. 2010. Age and sex differences in the clustering of metabolic syndrome factors: Association with mortality risk. Diabetes Care 33:2457-61
63. Kuk JL, Ross R. 2009. Influence of sex on total and regional fat loss in overweight and obese men and women. Int. J. Obes. 33:629-34
64. Kvist H, Chowdhury B, Granga°rd U, Tylen U, Sjostr öm L. 1988. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: Predictive equations. Am. J. Clin. Nutr. 48:1351-61
65. Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R, et al. 1998. Isoform specificity of trimethylamine N-oxygenation by human flavin-containingmonooxygenase (FMO)and p450 enzymes: Selective catalysis by FMO3. Biochem. Pharmacol. 56:1005-12
66. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres JP. 1993. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am. J. Clin. Nutr. 58:463-67
67. Li J, Chen X, Mc Clusky R, Ruiz-Sundstrom M, Itoh Y, et al. 2014. The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: One X is better than two. Cardiovasc. Res. 102:375-84
68. Lima R, Wofford M, Reckelhoff JF. 2012. Hypertension in postmenopausal women. Curr. Hypertens. Rep. 14:254-60
69. Link JC, Chen X, Arnold AP, Reue K. 2013. Metabolic impact of sex chromosomes. Adipocyte 2:74-79
70. Link JC, Chen X, Prien C, Borja MS, Hammerson B, et al. 2015. Increased high-density lipoprotein cholesterol levels in mice with XX versus XY sex chromosomes. Arterioscler. Thromb. Vasc. Biol. 35:1778-86
71. Liu J, Fox CS, Hickson DA, May WD, Hairston KG, et al. 2010. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: The Jackson Heart Study. J. Clin. Endocrinol. Metab. 95:5419-26
72. Lozupone C, Stombaugh J, Gordon J, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489:220-30
73. Lusis AJ, Attie AD, Reue K. 2008. Metabolic syndrome: From epidemiology to systems biology. Nat. Rev. Genet. 9:819-30
74. Maas AHEM, Appelman YEA. 2010. Gender differences in coronary heart disease. Neth.Heart J. 18:598-602
75. Magkos F, Mohammed BS, Mittendorfer B. 2008. Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women. Int. J. Obes. 32:1655-64
76. Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, et al. 2013. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339:1084-88
77. Mauvais-Jarvis F. 2015. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol. Sex Differ. 6:14
78. Melloni C, Berger JS, Wang TY, Gunes F, Stebbins A, et al. 2010. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ. Cardiovasc. Qual. Outcomes 3:135-42
79. Miller LR, Marks C, Becker JB, Hurn PD, Chen W-J, et al. 2017. Considering sex as a biological variable in preclinical research. FASEB J. 31:29-34
80. Mittendorfer B. 2005. Insulin resistance: Sex matters. Curr. Opin. Clin. Nutr. Metab. Care 8:367-72
81. Monroe AK, Dobs AS. 2013. The effect of androgens on lipids. Curr. Opin. Endocrinol. Diabetes Obes. 20:132-39
82. Mozumdar A, Liguori G. 2011. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 34:216-19
83. Murthy VH, Krumholz HM, Gross CP. 2004. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291:2720-26
84. Musatov S, Chen W, Pfaff DW, Mobbs C V, Yang X-J, et al. 2007. Silencing of estrogen receptor ?in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. PNAS 104:2501-6
85. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, et al. 2002. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51:2734-41
86. Nuutila P, Knuuti MJ, Mäki M, Laine H, Ruotsalainen U, et al. 1995. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 44:31-36
87. Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly M, et al. 2000. Obesity and disturbed lipoprotein profile in estrogen receptor-?-deficient male mice. Biochem. Biophys. Res. Commun. 278:640-45
88. Ong JP, Pitts A, Younossi ZM. 2008. Increased overall mortality and liver-related mortality in nonalcoholic fatty liver disease. J. Hepatol. 49:608-12
89. Org E, Mehrabian M, Parks BW, Shipkova P, Liu X, et al. 2016. Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes 7:313-22
90. Palmer BF, Clegg DJ. 2015. The sexual dimorphism of obesity. Mol. Cell. Endocrinol. 402:113-19
91. Pan J-J, Fallon MB. 2014. Gender and racial differences in nonalcoholic fatty liver disease. World J. Hepatol. 6:274-83
92. Parks BW, Nam E, Org E, Kostem E, Norheim F, et al. 2013. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 17:141-52
93. Parks BW, Sallam T, Mehrabian M, Psychogios N, Hui ST, et al. 2015. Genetic architecture of insulin resistance in the mouse. Cell Metab. 21:334-46
94. Paun A, Danska JS. 2016. Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome. Pediatr. Diabetes 17:469-77
95. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, et al. 2006. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. Circulation 113:898-918
96. Porter SA, Massaro JM, Hoffmann U, Vasan RS, O'Donnel CJ, Fox CS. 2009. Abdominal subcutaneous adipose tissue: A protective fat depot? Diabetes Care 32:1068-75
97. Pradhan AD. 2014. Sex differences in the metabolic syndrome: Implications for cardiovascular health in women. Clin. Chem. 60:44-52
98. Rochlani Y, Pothineni NV, Mehta JL. 2015. Metabolic syndrome: Does it differ between women and men? Cardiovasc. Drugs Ther. 29:329-38
99. Ruige JB, Mahmoud AM, De Bacquer D, Kaufman J-M. 2011. Endogenous testosterone and cardiovascular disease in healthy men: A meta-analysis. Heart 97:870-75
100. Sandberg K, Umans JG, Georget. Consens. Conf. Work Group. 2015. Recommendations concerning the new U.S. National Institutes of Health initiative to balance the sex of cells and animals in preclinical research. FASEB J. 29:1646-52
101. Senthong V, Wang Z, Li XS, Fan Y, Wu Y, et al. 2016. Intestinal microbiota-generated metabolite trimethylamine-N-oxide and 5-year mortality risk in stable coronary artery disease: The contributory role of intestinal microbiota in a COURAGE-like patient cohort. J. Am. Heart Assoc. 5:e002816
102. Shi H, Seeley RJ, Clegg DJ. 2009. Sexual differences in the control of energy homeostasis. Front. Neuroendocrinol. 30:396-404
103. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, et al. 2015. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518:187-96
104. Sung YJ, Perusse L, Sarzynski MA, Fornage M, Sidney S, et al. 2016. Genome-wide association studies suggest sex-specific loci associated with abdominal and visceral fat. Int. J. Obes. 40:662-74
105. Tang WHW, Hazen SL. 2017. Microbiome, trimethylamine N-oxide, and cardiometabolic disease. Transl. Res. 179:108-15
106. Tchernof A, Despres J-P. 2013. Pathophysiology of human visceral obesity: An update. Physiol. Rev. 93:359-404
107. Tjoa S, Fennessey P. 1991. The identification of trimethylamine excess in man: Quantitative analysis and biochemical origins. Anal. Biochem. 197:77-82
108. Tran TT, Yamamoto Y, Gesta S, Kahn CR. 2008. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 7:410-20
109. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3:213-23
110. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027-31
111. Unwin N, Shaw J, Zimmet P, Alberti KGMM. 2002. Impaired glucose tolerance and impaired fasting glycaemia: The current status on definition and intervention. Diabet. Med. 19:708-23
112. Wald C, Wu C. 2010. Of mice and women: The bias in animal models. Science 327:1571-72
113. Wang X, Magkos F, Mittendorfer B. 2011. Sex differences in lipid and lipoprotein metabolism: It's not just about sex hormones. J. Clin. Endocrinol. Metab. 96:885-93
114. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, et al. 2011. Gut florametabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472:57-63
115. Whitsel EA, Boyko EJ, Matsumoto AM, Anawalt BD, Siscovick DS. 2001. Intramuscular testosterone esters and plasma lipids in hypogonadal men: A meta-analysis. Am. J. Med. 111:261-69
116. Wise AL, Gyi L, Manolio TA. 2013. e Xclusion: Toward integrating the X chromosome in genome-wide association analyses. Am. J. Hum. Genet. 92:643-47
117. Xu Y, Nedungadi TP, Zhu L, Sobhani N, Irani BG, et al. 2011. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab. 14:453-65
118. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, et al. 2006. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 16:995-1004
119. Yasmeen R, Reichert B, Deiuliis J, Yang F, Lynch A, et al. 2013. Autocrine function of aldehyde dehydrogenase 1 as a determinant of diet-and sex-specific differences in visceral adiposity. Diabetes 62:124-36
120. Younossi ZM, Otgonsuren M, Venkatesan C, Mishra A. 2013. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism 62:352-60
121. Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, et al. 2012. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine 91:319-27
122. Zamboni M, Armellini F, Milani MP, De Marchi M, Todesco T, et al. 1992. Body fat distribution in pre-and post-menopausal women: Metabolic and anthropometric variables and their inter-relationships. Int. J. Obes. Relat. Metab. Disord. 16:495-504
123. Zarrinpar A, Chaix A, Yooseph S, Panda S. 2014. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab. 20:1006-17
124. Zhang H, Liu Y, Wang L, Li Z, Zhang H, et al. 2013. Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. J. Lipid Res. 54:345-57
125. Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, et al. 2016. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165:111-24